Stock screener

ARDX

Conviction 24HealthcareScan · Mon, Aug 10, 2026
ARDX$4.00-0.12%
ResistanceSupportVol 14Insider sell
63 bars
19
Vol MA14 4.4M
May 11May 28Jun 16Jul 6Jul 23Aug 10
ARDELYX, INC.PHARMACEUTICAL PREPARATIONSwww.ardelyx.com
Price4.00
Change-0.12%
Gap+1.25%
Rel volume2.22×
Avg volume3.94M
Avg $ vol18.41M
SMA 204.96
SMA 505.35
SMA 2006.02
Price vs 50-25.27%
Price vs 200-33.58%
MA stackbearish
50/200 cross
Supertrenddown · 4.79
RSI (14)19
MACD hist-0.08
MACD crossbear · 1d
Stoch %K / %D7 / 9
ADX (14)31
+DI / −DI8 / 38
RSI divergence
MACD divergence
ATR %+6.32%
ADR %3.75%
52w high7.99
52w low4.00
From 52w high-50.00%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width26.91%
%B-0.22
Donchian pos6.71%
Donchian high5.32
Donchian low3.90
AVWAP (52w high)5.97
vs AVWAP high-33.10%
AVWAP (52w low)4.04
vs AVWAP low-1.16%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d2.22×
Avg vol (14d)4.4M
Avg vol (20d)3.94M
Avg $ vol (20d)18.41M
Market cap995.5M
RS 3m (vs SPY)-48.39%
RS 6m (vs SPY)-56.97%
RS line new highNo
Trend template1/8
Technical rank5.7
1 week-19.78%
1 month-24.34%
3 months-41.08%
6 months-45.42%
1 year-22.28%
YTD-35.04%
P/E-16.16
P/B6.68
P/S2.44
P/FCF-22.64
EPS-0.2600
Div yield
ROE-41.34%
ROA-10.70%
Debt/Eq0.18
Current3.34
EV/EBITDA-24.39
Gross margin1.15%
Net margin-15.12%
Rev growth22.09%
EPS growth-57.40%
Price target14.86
Target upside271.96%
Analyst ratingBuy
Institutional80.12%
Ent. value924.85M
Revenue120.88M
Net income-16.72M
Gross profit2.41M
Free cash flow-43.98M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out247.03M
Employees489
ListedThu, Jun 19, 2014
Free float235.27M
Float %96.8%
Short interest26.25M
Days to cover8.1d
Short volume27.4%
Squeeze score62 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.07 vs −$0.05
Last surprise-40.0% miss
Setup gradeD
Conviction24 / 100
Pattern quality
Tech rank5.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance6.02
Support4.95
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARDX

All disclosures →
No recent disclosed trades by Congress in ARDX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARDX · 6 buys · 4 sells

InsiderSideShares
RAAB MICHAEL
President & CEO · Common Stock · 2026-07-15
Exercise20.83K
RAAB MICHAEL
President & CEO · Common Stock · 2026-07-15
Sell41.67K
RAAB MICHAEL
President & CEO · Stock Option (Right to Buy) · 2026-07-15
Exercise20.83K
Williams Laura A
Chief Patient Officer · Common Stock · 2026-06-18
Exercise31K
Williams Laura A
Chief Patient Officer · Common Stock · 2026-06-18
Sell81.9K
Williams Laura A
Chief Patient Officer · Stock Option (Right to Buy) · 2026-06-18
Exercise31K
Bhanji Muna
Director · Common Stock · 2026-06-16
Grant26.45K
MOTT DAVID M
Director · Common Stock · 2026-06-16
Grant20.28K
MOTT DAVID M
Director · Common Stock · 2026-06-16
Grant26.45K
MOTT DAVID M
Director · Stock Option (Right to Buy) · 2026-06-16
Grant39.72K

SEC filings

EDGAR filings in ARDX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.